Humanized tumor mice-A new model to study and manipulate the immune response in advanced cancer therapy
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Humanized tumor mice-A new model to study and manipulate the immune response in advanced cancer therapy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 129, Issue 9, Pages 2194-2206
Publisher
Wiley
Online
2011-05-05
DOI
10.1002/ijc.26159
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Innate NK Cells, Allograft Rejection, and a Key Role for IL-15
- (2014) A. Kroemer et al. JOURNAL OF IMMUNOLOGY
- Monoclonal Antibodies in Clinical Oncology
- (2012) S. Dalle et al. Anti-Cancer Agents in Medicinal Chemistry
- In vivo assay of human NK-dependent ADCC using NOD/SCID/γcnull (NOG) mice
- (2010) Miho Shiokawa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence
- (2010) T. Strowig et al. BLOOD
- A complement-dependent cytotoxicity-enhancing anti-CD20 antibody mediating potent antitumor activity in the humanized NOD/Shi-scid, IL-2Rγnull mouse lymphoma model
- (2010) Fumihiko Sato et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Intrahepatically transplanted human cord blood cells reduce SW480 tumor growth in the presence of bispecific EpCAM/CD3 antibody
- (2010) Annika Wulf-Goldenberg et al. CYTOTHERAPY
- Establishment of a rhabdomyosarcoma xenograft model in human-adapted mice
- (2010) Seitz ONCOLOGY REPORTS
- Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r null humanized mice
- (2010) L. D. Shultz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Breast tumor cells isolated from in vitro resistance to trastuzumab remain sensitive to trastuzumab anti-tumor effects in vivo and to ADCC killing
- (2009) Timothy E. Kute et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Defucosylated Anti-CCR4 Monoclonal Antibody Exerts Potent ADCC against Primary ATLL Cells Mediated by Autologous Human Immune Cells in NOD/Shi-scid, IL-2R null Mice In Vivo
- (2009) A. Ito et al. JOURNAL OF IMMUNOLOGY
- Suppression of Human Immunodeficiency Virus Type 1 (HIV-1) Viremia with Reverse Transcriptase and Integrase Inhibitors, CD4+ T-Cell Recovery, and Viral Rebound upon Interruption of Therapy in a New Model for HIV Treatment in the Humanized Rag2-/- c-/- Mouse
- (2009) S. K. Choudhary et al. JOURNAL OF VIROLOGY
- Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rγnull mouse model
- (2008) Asahi Ito et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IL-15 trans-presentation promotes human NK cell development and differentiation in vivo
- (2008) Nicholas D. Huntington et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cancer Immunology
- (2008) Olivera J. Finn NEW ENGLAND JOURNAL OF MEDICINE
- Antiretroviral Pre-exposure Prophylaxis Prevents Vaginal Transmission of HIV-1 in Humanized BLT Mice
- (2008) Paul W Denton et al. PLOS MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More